Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy
Authors:
- Thomas GremmelTGThomas Gremmel
- Sabine SteinerSSSabine Steiner
- Daniela SeidingerDSDaniela Seidinger
- Renate KoppensteinerRKRenate Koppensteiner
- Simon PanzerSPSimon Panzer
- Christoph W. KoppCKChristoph W. Kopp
- 1 November 2009
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 124 (5) , 588-591
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromesThrombosis and Haemostasis, 2007
- ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndromeThrombosis and Haemostasis, 2007
- Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome of Elective Coronary Stent PlacementJACC, 2006
- Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantationEuropean Heart Journal, 2006
- P2Y12 receptor antagonists: a rapidly expanding group of antiplatelet agentsThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.European Heart Journal, 2006
- Platelet Reactivity in Patients and Recurrent Events Post-StentingJACC, 2005
- Variability in platelet responsiveness to clopidogrel among 544 individualsJACC, 2005
- Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial InfarctionCirculation, 2004
- Clopidogrel for Coronary StentingCirculation, 2003
- The Antiplatelet Effects of Ticlopidine and ClopidogrelAnnals of Internal Medicine, 1998